89250-15-7

Usage

Uses

Used in Pharmaceutical Industry:
4-(1-Methyl-5-iMidazolyl)aniline is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique chemical structure allows it to be a key component in the development of new medications with potential therapeutic benefits.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(1-Methyl-5-iMidazolyl)aniline serves as a reagent, contributing to the formation of complex organic compounds. Its presence in reactions can facilitate the synthesis of desired products, making it a valuable tool for chemists.
Used in Research and Development:
4-(1-Methyl-5-iMidazolyl)aniline is utilized in research and development for exploring its potential biological and pharmacological activities. Studies on 4-(1-Methyl-5-iMidazolyl)aniline can lead to a better understanding of its properties and applications, paving the way for new discoveries and innovations in the scientific community.

Upstream product

• 774238-44-7 N-[4-(3-methyl-3H-imidazol-4-yl)phenyl]acetamide 
• 61278-68-0 1-methyl-5-(4-nitrophenyl)-1H-imidazole 

Downstream Products

• 89250-49-7 N-cyano-N'-(4-1-methyl-1H-imidazol-5-ylphenyl)formamidine 

Relevant academic research and scientific papers

HYDRAZONE DERIVATIVE

A compound represented by the following formula (I): wherein R1 represents hydrogen, aryl which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc.; R2 represents hydrogen, aryl which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc.; R3 represents hydrogen, etc.; Ar represents a divalent group derived from aromatic hydrocarbon, etc.; X represents a single bond, linear or branched alkylene having from 1 to 3 carbon atoms which may have a substituent, etc.; and G represents halogen, a saturated or unsaturated 5- or 6-membered cyclic hydrocarbon group which may have a substituent, a saturated or unsaturated 5- to 7-membered heterocyclic group which may have a substituent, etc., a salt thereof or a solvate thereof; and an agent for inhibiting aggregation and/or deposition of an amyloid protein or an amyloid-like protein, which comprises the compound, a salt thereof or a solvate thereof

Ionization, tautomerism and molecular conformation in aqueous solution of the histamine H2-receptor antagonist mifentidine

Ionization (pK(a)) and tautomeric (K(t)) constants of mifentidine (DA4577) have been determined in aqueous solution. The predominant molecular species at physiological pH (7.4) is the monocationic form (95.3%) at the formamidine moiety, with the imidazole